Topics - Statement on the benefit assessment of ivosidenib (patients with locally advanced or metastatic cholangiocarcinoma (CCA)) from November 6, 2023

ZEITSCHRIFT FUR GASTROENTEROLOGIE(2024)

引用 0|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要